Adelaide Research & Scholarship: Browsing DSpace

Browsing "Pharmacology" by Author Sallustio, B.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:

Showing results 26 to 41 of 41 < previous

Preview	Issue Date	Title	Author(s)
	1998	Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service	Morris, R.; Black, A.; Harris, A.; Batty, A.; Sallustio, B.
	2010	LC-MS/MS for immunosuppressant therapeutic drug monitoring	Sallustio, B.
	2011	Measurement of Cyclosporine A in rat tissues and human kidney transplant biopsies - A method suitable for small (<1 mg) samples	Noll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
	2004	Optimisation of the comet genotoxicity assay in freshly isolated murine hepatocytes: detection of strong in vitro DNA damaging properties for styrene	Fontaine, F.; DeGraaf, Y.; Ghaoui, R.; Sallustio, B.; Edwards, J.; Burcham, P.
	2002	Pharmacokinetics of the antianginal agent perhexiline: relationship between metabolic ratio and steady-state dose	Sallustio, B.; Westley, I.; Morris, R.
	1995	Reactivity of gemfibrozil 1-0-b acyl glucuronide: Pharmacokinetics of covalently bound gemfibrozil-protein adducts in rats	Sallustio, B.; Foster, D.
	2003	Relationship between CYP2D6 genotype and plasma OH-perhexiline/perhexiline concentration ratio in angina patients.	Sallustio, B.; Davies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.
	2014	Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake	Drury, N.; Licari, G.; Chong, C.; Howell, N.; Frenneaux, M.; Horowitz, J.; Pagano, D.; Sallustio, B.
	2006	Role of MRP2 in the hepatic disposition of mycophenolic acid and its glucuronide metabolites: Effect of cyclosporine	Westley, I.; Brogan, L.; Morris, R.; Evans, A.; Sallustio, B.
	1999	Some international approaches to aminoglycoside monitoring in the extended dosing interval era	Morris, R.; Sallustio, B.; Vinks, A.; LeGatt, D.; Verjee, Z.; Desoky, E.
	2008	Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexiline	Davies, B.; Herbert, M.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
	2005	The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia	Davies, B.; Coller, J.; James, H.; Somogyi, A.; Horowitz, J.; Sallustio, B.
	2003	UDP-glucuronosyltransferase-dependent bioactivation of clofibric acid to a DNA-damaging intermediate in mouse hepatocytes	Ghaoui, R.; Sallustio, B.; Burcham, P.; Fontaine, F.
	2005	Validation of a high-performance liquid chromatography method for the measurement of mycophenolic acid and its glucuronide metabolites in plasma	Westley, I.; Sallustio, B.; Morris, R.
	2014	Validation of an LC-MS/MS method for the quantification of mycophenolic acid in human kidney transplant biopsies	Md Dom, Z.; Noll, B.; Coller, J.; Somogyi, A.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.
	2013	Validation of an LC-MS/MS method to measure tacrolimus in rat kidney and liver tissue and its application to human kidney biopsies	Noll, B.; Coller, J.; Somogyi, A.; Morris, R.; Russ, G.; Hesselink, D.; van Gelder, T.; Sallustio, B.

Showing results 26 to 41 of 41 < previous